Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Rose Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) climbed 5% on Thursday as the biotech progressed toward a major vaccine development milestone.

Late on Thursday, the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee recommended authorization of Moderna's vaccine candidate for emergency use. The advisory committee helps assure vaccines are safe for the public. The FDA isn't required to follow its recommendations, but typically does.

Moderna's stock popped on Thursday. Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share